533 related articles for article (PubMed ID: 26308415)
1. Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?
Ericzon BG; Wilczek HE; Larsson M; Wijayatunga P; Stangou A; Pena JR; Furtado E; Barroso E; Daniel J; Samuel D; Adam R; Karam V; Poterucha J; Lewis D; Ferraz-Neto BH; Cruz MW; Munar-Ques M; Fabregat J; Ikeda S; Ando Y; Heaton N; Otto G; Suhr O
Transplantation; 2015 Sep; 99(9):1847-54. PubMed ID: 26308415
[TBL] [Abstract][Full Text] [Related]
2. Survival After Transplantation in Patients With Mutations Other Than Val30Met: Extracts From the FAP World Transplant Registry.
Suhr OB; Larsson M; Ericzon BG; Wilczek HE;
Transplantation; 2016 Feb; 100(2):373-81. PubMed ID: 26656838
[TBL] [Abstract][Full Text] [Related]
3. Continuous development of arrhythmia is observed in Swedish transplant patients with familial amyloidotic polyneuropathy (amyloidogenic transthyretin Val30Met variant).
Okamoto S; Hörnsten R; Obayashi K; Wijayatunga P; Suhr OB
Liver Transpl; 2011 Feb; 17(2):122-8. PubMed ID: 21280184
[TBL] [Abstract][Full Text] [Related]
4. Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant.
Sattianayagam PT; Hahn AF; Whelan CJ; Gibbs SD; Pinney JH; Stangou AJ; Rowczenio D; Pflugfelder PW; Fox Z; Lachmann HJ; Wechalekar AD; Hawkins PN; Gillmore JD
Eur Heart J; 2012 May; 33(9):1120-7. PubMed ID: 21992998
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation in transthyretin amyloidosis: issues and challenges.
Carvalho A; Rocha A; Lobato L
Liver Transpl; 2015 Mar; 21(3):282-92. PubMed ID: 25482846
[TBL] [Abstract][Full Text] [Related]
6. Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy.
Coelho T; Inês M; Conceição I; Soares M; de Carvalho M; Costa J
Neurology; 2018 Nov; 91(21):e1999-e2009. PubMed ID: 30333157
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Dysautonomia Predicts Long-Term Survival in Hereditary Transthyretin Amyloidosis After Liver Transplantation.
Algalarrondo V; Antonini T; Théaudin M; Chemla D; Benmalek A; Lacroix C; Castaing D; Cauquil C; Dinanian S; Eliahou L; Samuel D; Adams D; Le Guludec D; Slama MS; Rouzet F
JACC Cardiovasc Imaging; 2016 Dec; 9(12):1432-1441. PubMed ID: 27838303
[TBL] [Abstract][Full Text] [Related]
8. Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy.
Coutinho MC; Cortez-Dias N; Cantinho G; Conceição I; Oliveira A; Bordalo e Sá A; Gonçalves S; Almeida AG; de Carvalho M; Diogo AN
Circ Cardiovasc Imaging; 2013 Sep; 6(5):627-36. PubMed ID: 23833285
[TBL] [Abstract][Full Text] [Related]
9. Outcome in patients treated with isolated liver transplantation for familial transthyretin amyloidosis to prevent cardiomyopathy.
Nelson LM; Penninga L; Villadsen GE; Mølgaard H; Eiskjaer H; Hillingsø JG; Rasmussen A
Clin Transplant; 2015 Dec; 29(12):1098-104. PubMed ID: 26361241
[TBL] [Abstract][Full Text] [Related]
10. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry.
Herlenius G; Wilczek HE; Larsson M; Ericzon BG;
Transplantation; 2004 Jan; 77(1):64-71. PubMed ID: 14724437
[TBL] [Abstract][Full Text] [Related]
11. Progression of transthyretin (TTR) amyloidosis in donors and recipients after domino liver transplantation-a prospective single-center cohort study.
Vollmar J; Schmid JC; Hoppe-Lotichius M; Barreiros AP; Azizi M; Emrich T; Geber C; Schad A; Weyer V; Otto G; Heise M; Mittler J; Birklein F; Lang H; Galle PR; Zimmermann T
Transpl Int; 2018 Nov; 31(11):1207-1215. PubMed ID: 30091268
[TBL] [Abstract][Full Text] [Related]
12. Amyloid fibril composition as a predictor of development of cardiomyopathy after liver transplantation for hereditary transthyretin amyloidosis.
Gustafsson S; Ihse E; Henein MY; Westermark P; Lindqvist P; Suhr OB
Transplantation; 2012 May; 93(10):1017-23. PubMed ID: 22395298
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy.
Yamashita T; Ando Y; Okamoto S; Misumi Y; Hirahara T; Ueda M; Obayashi K; Nakamura M; Jono H; Shono M; Asonuma K; Inomata Y; Uchino M
Neurology; 2012 Feb; 78(9):637-43. PubMed ID: 22345221
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type).
Suhr OB; Ericzon BG; Friman S
Liver Transpl; 2002 Sep; 8(9):787-94. PubMed ID: 12200779
[TBL] [Abstract][Full Text] [Related]
15. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan.
Ueda M; Yamashita T; Misumi Y; Masuda T; Ando Y
Amyloid; 2018 Sep; 25(3):143-147. PubMed ID: 30486687
[TBL] [Abstract][Full Text] [Related]
16. Liver transplantation for hereditary transthyretin amyloidosis.
Suhr OB; Herlenius G; Friman S; Ericzon BG
Liver Transpl; 2000 May; 6(3):263-76. PubMed ID: 10827225
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with polyneuropathy after liver transplantation.
Okumura K; Yamashita T; Masuda T; Misumi Y; Ueda A; Ueda M; Obayashi K; Jono H; Yamashita S; Inomata Y; Ando Y
Amyloid; 2016; 23(1):39-45. PubMed ID: 26763274
[TBL] [Abstract][Full Text] [Related]
18. Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications.
Suhr OB
Amyloid; 2003 Aug; 10 Suppl 1():77-83. PubMed ID: 14640045
[TBL] [Abstract][Full Text] [Related]
19. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.
Coelho T; Maurer MS; Suhr OB
Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944
[TBL] [Abstract][Full Text] [Related]
20. Family dynamics in transthyretin-related familial amyloid polyneuropathy Val30Met: Does genetic risk affect family functioning?
Lopes A; Rodrigues C; Fonseca I; Sousa A; Branco M; Coelho T; Sequeiros J; Freitas P
Clin Genet; 2018 Nov; 94(5):401-408. PubMed ID: 30019395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
